Holding/activity history for Eli Lilly & Co. (LLY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 124,539 | 1.94 | $885.94 | ||
| 2024 Q2 | 124,539 | 2.03 | $905.38 | ||
| 2024 Q1 | 124,539 | 1.78 | $777.96 | ||
| 2023 Q4 | 124,539 | 1.45 | Reduce 8.12% | 0.13 | $582.92 |
| 2023 Q3 | 135,539 | 1.62 | Reduce 16.33% | 0.32 | $537.13 |
| 2023 Q2 | 162,000 | 1.57 | Reduce 19.00% | 0.37 | $468.98 |
| 2023 Q1 | 200,000 | 1.51 | Add 43.88% | 0.46 | $343.42 |
| 2022 Q4 | 139,000 | 1.18 | $365.84 | ||
| 2022 Q3 | 139,000 | 1.07 | Reduce 8.55% | 0.10 | $323.35 |
| 2022 Q2 | 152,000 | 1.11 | Reduce 40.39% | 0.75 | $324.23 |
| 2022 Q1 | 255,000 | 1.35 | $286.37 | ||
| 2021 Q4 | 255,000 | 1.19 | $276.22 | ||
| 2021 Q3 | 255,000 | 1.08 | $231.05 | ||
| 2021 Q2 | 255,000 | 1.07 | $229.52 | ||
| 2021 Q1 | 255,000 | 0.94 | $186.82 | ||
| 2020 Q4 | 255,000 | 0.89 | $168.84 | ||
| 2020 Q3 | 255,000 | 0.87 | $148.02 | ||
| 2020 Q2 | 255,000 | 1.01 | Reduce 23.66% | 0.31 | $164.18 |
| 2020 Q1 | 334,031 | 1.29 | Reduce 4.30% | 0.06 | $138.72 |
| 2019 Q4 | 349,031 | 1.00 | Add 52.39% | 0.34 | $131.43 |
| 2019 Q3 | 229,031 | 0.59 | Add 4.57% | 0.03 | $111.83 |
| 2019 Q2 | 219,031 | 0.56 | $110.79 | ||
| 2019 Q1 | 219,031 | 0.66 | Reduce 29.34% | 0.27 | $129.76 |
| 2018 Q4 | 310,000 | 0.92 | Reduce 21.52% | 0.25 | $115.72 |
| 2018 Q3 | 395,000 | 0.94 | Reduce 14.13% | 0.15 | $107.31 |
| 2018 Q2 | 460,000 | 0.92 | $85.33 | ||
| 2018 Q1 | 460,000 | 0.82 | $77.37 | ||
| 2017 Q4 | 460,000 | 0.83 | Add 2.22% | 0.02 | $84.46 |
| 2017 Q3 | 450,000 | 0.88 | Add 13.92% | 0.11 | $85.54 |
| 2017 Q2 | 395,000 | 0.72 | Add 31.67% | 0.17 | $82.30 |
| 2017 Q1 | 300,000 | 0.56 | Buy | 0.56 | $84.11 |